GlaxoSmithKline

Gsk And Sk Bioscience Start Late-Stage Trial Of Covid Vaccine
Covid

GSK and SK Bioscience start late-stage trial of Covid vaccine
Sanofi/Glaxosmithkline Covid-19 Vaccine Enters Final Trials
World

Sanofi/GlaxoSmithKline Covid-19 vaccine enters final trials
Gsk And Sanofi Aim For Covid Booster Jab Following Successful Phase 2 Trial
Covid

GSK and Sanofi aim for Covid booster jab following successful phase 2 trial
European Agency Begins Fast-Track Study Of Experimental Covid Treatment
World

European agency begins fast-track study of experimental Covid treatment
New Antibody Drug ‘Reduces Hospital Admission Or Death From Covid-19 By 85%’
World

New antibody drug ‘reduces hospital admission or death from Covid-19 by 85%’
J&Amp;J Applies For Emergency Approval For One-Shot Vaccine
World

J&J applies for emergency approval for one-shot vaccine
Advertisement
Glaxosmithkline And Curevac To Make Covid Vaccines Targeting New Variants
World

GlaxoSmithKline and CureVac to make Covid vaccines targeting new variants
France’s Sanofi To Make Covid Vaccines From Rival Pfizer/Biontech
World

France’s Sanofi to make Covid vaccines from rival Pfizer/BioNTech
‘Slim Chance’ Of A Covid Vaccine Before Christmas, Says Expert
World

‘Slim chance’ of a Covid vaccine before Christmas, says expert
Uk Patient Receives Experimental Arthritis Drug In Trial For Severe Covid-19
World

UK patient receives experimental arthritis drug in trial for severe Covid-19
Uk Government Signs Deal With Gsk And Sanofi For Potential Covid-19 Vaccine
World

UK Government signs deal with GSK and Sanofi for potential Covid-19 vaccine
Advertisement
Gsk Throws £130M Behind Innovative Vaccine Developer Curevac
World

GSK throws £130m behind innovative vaccine developer CureVac
IAB logo
The Irish Times DAC
24-28 Tara Street,
Dublin 2,
D02 CX89
Company Number: 2514
desk@breakingnews.ie Phone: +353 1 531 0971
© BreakingNews.ie 2024, developed by Square1 and powered by PublisherPlus.com